Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arch Therapeutics, Inc. (ARTH) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arch Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1537561.
Total stock buying since 2016: $7,547.
Total stock sales since 2016: $0.
Total stock option exercises since 2016: $11,100.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 27,446 | $7,547 | 0 | $0 | 0 | $0 |
| 2018 | 0 | $0 | 0 | $0 | 30,000 | $11,100 |
| 2016 | 111,111 | $0 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-08 | 27,446 | $7,547 | 0 | $0 | 0 | $0 |
| 2018-07 | 0 | $0 | 0 | $0 | 30,000 | $11,100 |
| 2016-05 | 111,111 | $0 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-31 | Hicks Laurence (Director) | Buy | 10,292 | .28 | 2,830 |
| 2023-08-31 | Norchi Terrence W (PRESIDENT AND CHIEF EXECUTIVE) | Buy | 6,862 | .28 | 1,887 |
| 2023-08-31 | Abrams Michael S (CHIEF FINANCIAL OFFICER) | Buy | 10,292 | .28 | 2,830 |
| 2018-07-16 | Sulat James R | Option Ex | 30,000 | .37 | 11,100 |
| 2016-05-26 | Sulat James R | Buy | 111,111 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of ARTH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arch Therapeutics, Inc. (symbol ARTH, CIK number 1537561) see the Securities and Exchange Commission (SEC) website.